NCT05305001View on ClinicalTrials.gov

Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico

CompletedOBSERVATIONAL

Enrollment

107

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Pancreatic CancerPancreatic Adenocarcinoma

Interventions

GENETIC

Invitae Multi-Cancer Panel ®

Participants will have genetic testing.

Trial Locations (1)

14080

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City

All Listed Sponsors

lead

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

OTHER

NCT05305001 - Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico | Biotech Hunter | Biotech Hunter